SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,410.74 -272.93
(-0.55%)

Dow Jones

6,881.90 -20.41
(-0.30%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

90.70 0.01
(0.01%)

EUR-INR

107.23 -0.14
(-0.13%)

GBP-INR

122.83 -0.27
(-0.22%)

JPY-INR

0.59 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Terce Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524314

INE499G01013

10.0907008

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

30.54

EPS(TTM)

Face Value()

Div & Yield %

Back

KIC Metaliks reports standalone net loss of Rs 1.15 crore in the June 2025 quarter

Aug 13,2025

Net loss of KIC Metaliks reported to Rs 1.15 crore in the quarter ended June 2025 as against net profit of Rs 0.85 crore during the previous quarter ended June 2024. Sales declined 15.07% to Rs 152.00 crore in the quarter ended June 2025 as against Rs 178.97 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	152.00	178.97	-15
OPM %	2.33	4.02	-
PBDT	2.16	4.53	-52
PBT	-1.57	0.81	PL
NP	-1.15	0.85	PL

82,814.71 316.57 ( 0.38%)

49,410.74 -272.93 (-0.55%)

6,881.90 -20.41 (-0.30%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

90.70 0.01 (0.01%)

107.23 -0.14 (-0.13%)

122.83 -0.27 (-0.22%)

0.59 0.00 (-0.51%)